CELLDEX THERAPEUTICS INC NEW's ticker is CLDXXXXX and the CUSIP is 15117B103. A total of 165 filers reported holding CELLDEX THERAPEUTICS INC NEW in Q3 2015. The put-call ratio across all filers is 4.61 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $3,000 | -70.0% | 15,001 | -29.5% | 0.00% | -100.0% |
| Q3 2018 | $10,000 | -16.7% | 21,293 | -10.4% | 0.00% | 0.0% |
| Q2 2018 | $12,000 | -55.6% | 23,761 | +106.3% | 0.00% | 0.0% |
| Q1 2018 | $27,000 | -73.0% | 11,516 | -67.1% | 0.00% | -80.0% |
| Q3 2017 | $100,000 | -67.0% | 34,975 | +191.0% | 0.01% | -81.5% |
| Q2 2015 | $303,000 | – | 12,020 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ridgeback Capital Investments L.P. | 1,025,000 | $24,815,000 | 31.36% |
| TSP Capital Management Group, LLC | 836,342 | $20,248,000 | 8.80% |
| Iguana Healthcare Management, LLC | 200,000 | $4,842,000 | 2.76% |
| First Light Asset Management, LLC | 116,096 | $2,811,000 | 2.38% |
| SECTORAL ASSET MANAGEMENT INC | 2,227,688 | $53,932,000 | 2.33% |
| BENNETT LAWRENCE MANAGEMENT L L C/NY | 550,735 | $13,334,000 | 2.05% |
| Eventide Asset Management | 257,000 | $6,222,000 | 1.92% |
| Redmile Group, LLC | 397,951 | $9,634,000 | 1.19% |
| ARDSLEY ADVISORY PARTNERS LP | 357,000 | $8,643,000 | 1.15% |
| Rhenman & Partners Asset Management AB | 90,000 | $2,179,000 | 0.85% |